Plasma membrane and intracellular lipid synthesis in tumor cells rendered sensitive to humoral immune killing after treatment with metabolic inhibitors
- PMID: 292816
Plasma membrane and intracellular lipid synthesis in tumor cells rendered sensitive to humoral immune killing after treatment with metabolic inhibitors
Abstract
Line 10 guinea pigs hepatoma cells are resistant to killing by antibody and guinea pig complement. Metabolic inhibitors (adriamycin and actinomycin D) that increase the sensitivity of the cells to antibody-complement (C) killing were examined for their effects on the ability of the cells to synthesize and incorporate specific lipids into plasma membrane and intracellular membrane fractions. Drug-treated cells that had been rendered sensitive to antibody-C killing were inhibited in their incorporation of newly synthesized phosphatidylcholine and cholesteryl ester into the plasma membrane, as well as incorporation of phosphatidylcholine, cardiolipin, cholesteryl ester, and triglyceride into certain intracellular organelles including mitochondria, endoplasmic reticulum, nuclear membrane, or microsomes. Drug-treated cells recultured in the absence of the drug regained their ability to resist antibody-C killing and to synthesize and incorporate lipids into plasma and intracellular membranes. These data suggested that agents modifying the sensitivity of the tumor cells to humoral immune killing have a concomitant effect on plasma membrane and intracellular lipid synthesis.
Similar articles
-
Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.J Natl Cancer Inst. 1980 Apr;64(4):943-50. J Natl Cancer Inst. 1980. PMID: 6988626
-
Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.J Natl Cancer Inst. 1978 Sep;61(3):931-4. J Natl Cancer Inst. 1978. PMID: 278869
-
Identification of lipids associated with the ability of tumor cells to resist humoral immune attack.J Immunol. 1978 Feb;120(2):472-80. J Immunol. 1978. PMID: 202653
-
Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.Crit Rev Immunol. 1981 Jan;1(3):165-209. Crit Rev Immunol. 1981. PMID: 6174273 Review.
-
Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.Cancer Treat Rep. 1983 Oct;67(10):895-9. Cancer Treat Rep. 1983. PMID: 6354437 Review.
Cited by
-
Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells.Front Immunol. 2022 Feb 15;13:768606. doi: 10.3389/fimmu.2022.768606. eCollection 2022. Front Immunol. 2022. PMID: 35250970 Free PMC article. Review.